Argatroban and heparin-induced thrombocytopenia

Completed

Phase N/A Results

Summary of Purpose

To evaluate the prophylactic efficacy of argatroban against ischemic stroke in patients with heparin-induced thrombocytopenia.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • University of Maryland School of Medicine

Trial Design

Retrospective, controlled study.

Contacts

  • Brown PM, Hursting MJ.

    mlamonte@umm.edu